Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Caliper and Seegene combine for diagnostic assays pact

This article was originally published in Clinica

Executive Summary

Korean firm Seegene is to make its complete line of multiplex diagnostic assays available on Caliper Life Sciences’ LabChip Dx platform. Under the terms of the deal, the two companies will co-market the LabChip Dx platform as the system of choice for Seegene’s SeePlex assays outside of the US. The firms will also work together to expand the number of diagnostic tests available on the LabChip system. Caliper (Hopkinton, Massachusetts) says LabChip is a high-throughput, multiplex, sample-processing, microfluidic system that includes diagnostic identification, scoring and reporting software. It was developed in collaboration with Seoul-based Seegene. Seegene’s assays use dual priming oligonucleotide technology, which detects many pathogens in a single reaction and can be used on electrophoresis platforms. The assays test for a range of pathogens, and allow screening for respiratory diseases, human papillomavirus, Candida, sepsis, diarrhoea, meningitis, tuberculosis and STDs. Financial terms of the deal were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel